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Abstract     
In older populations, caregiving for a spouse with dementia has been associated with a 
poor antibody response to vaccination.  The present study examined whether younger 
caregivers, specifically the parents of children with developmental disabilities, would 
also show a diminished antibody response to vaccination.  At baseline assessment, 30 
parents of children with developmental disabilities and 29 parents of typically 
developing children completed standard measures of depression, perceived stress, social 
support, caregiver burden, and child problem behaviours.  They also provided a blood 
sample and were then vaccinated with a pneumococcal polysaccharide vaccine.  Further 
blood samples were taken at 1- and 6-month follow-ups.  Caregivers mounted a poorer 
antibody response to vaccination than control parents at both follow-ups.  This effect 
withstood adjustment for a number of possible confounders and appeared to be, at least 
in part, mediated by child problem behaviours.  The negative impact of caregiving on 
antibody response to vaccination is not restricted to older spousal caregivers, but is also 
evident in younger parents caring for children with developmental disabilities. The 
behavioural characteristics of the care recipients may be a key consideration in whether 
or not immunity is compromised in this context.  
 
Keywords:  Antibody response; Caregiving; Children with developmental disabilities; 
Child problem behaviours; Chronic stress; Pneumococcal vaccination 
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      Antibody response to vaccination provides a useful model for studying psychosocial 
influences on in vivo immune function (Burns et al., 2003a; Phillips and Burns, 2008; 
Vedhara et al., 1999a).  Stress, whether measured as life events exposure, perceived 
stress, or negative affect has been found to be inversely associated with the antibody 
response to a variety of medical vaccinations (Burns et al., 2003b; Burns et al., 2002; 
Gallagher et al., 2008a; Marsland et al., 2001; Phillips et al., 2005; Phillips et al., 2006), 
implying that those experiencing stress have a reduced capacity to fight viral and 
bacterial infections.  In humans, the effects of chronic stress on immunity have mainly 
been studied by comparing non-routine caregivers and broadly matched controls 
(Kiecolt-Glaser et al., 1991; Kiecolt-Glaser et al., 1987; Mills et al., 2004; Redwine et 
al., 2004; Vedhara et al., 1999b; Vitaliano et al., 1998).  There is now reasonable 
consensus that older spousal caregivers of dementia patients have a relatively poor 
response to both influenza and pneumococcal vaccinations (Glaser et al., 2000; Kiecolt-
Glaser et al., 1996; Vedhara et al., 1999a).  However, younger caregivers have rarely 
been studied in this context.   
 
      The only published vaccination study to target younger caregivers found no 
differences in antibody response to influenza vaccination between those caring for a 
spouse with multiple sclerosis and controls (Vedhara et al., 2002).  This raises the issue 
of whether the poor antibody response observed in older caregivers is, to an extent, a 
function of an interaction between chronic stress exposure and immuosenescence, and 
accordingly will be less likely to occur in younger caregivers (Graham et al., 2006; 
Kiecolt-Glaser et al., 2003).  Indeed, a recent study from our group supports such a 
notion (Gallagher et al., 2008b).  S-IgA secretion rates were found to be lower in non-
routine caregivers relative to controls, but only for the oldest of three distinct age 
cohorts.  Nevertheless, analysis within the caregiving group indicated that for the 
youngest and the middle-aged cohorts, S-IgA secretion rates varied negatively with 
caregiving burden and strain.   
       
      There is, however, an alternative explanation for the discrepancy in outcomes among 
the caregiver vaccination studies.  Rather than immuosenescence, it is possible that it is 
Post-print, not final published version. Cite this article as:  Gallagher, S., Phillips, A.C., 
Drayson, M., & Carroll., D. (2009, invited article). Parental caregivers of children with 
developmental disabilities mount a poor antibody response to pneumococcal vaccination. Brain, 
Behavior & Immunity, 23, 338-346. DOI: 10.1016/j.bbi.2008.05.006. 
http://dx.doi.org/10.1016/j.bbi.2008.05.006 
 
 4
the intensity of the chronic stress experienced that determines whether caregiving 
becomes an issue for immunity (Vedhara et al., 2002).  Dementia is a disease 
characterised by much more severe cognitive and behavioural disturbances than multiple 
sclerosis (Gregory and Hodges, 1996; Keegan and Noseworthy, 2002; Neary et al., 1998; 
Poser et al., 1983).  Accordingly, the precise caregiving experience will vary between 
those caring for patients with multiple sclerosis and dementia.   Indeed, older spousal 
caregivers of dementia patients have been found to report greater distress than younger 
multiple sclerosis caregivers (Vedhara et al., 2002).  Further, the results of two recent 
meta-analyses indicate that caregivers of dementia patients generally experience greater 
burden and report more symptoms of depression than those caring for non-dementia, e.g., 
cancer patients, (Pinquart and Sorensen, 2003a, b).  Thus, it might be hypothesized that, 
irrespective of the caregiver’s age, caring for someone with severe cognitive and 
behavioural problems will compromise immunity.   
 
      A model which would allow us to shed light on these competing propositions is 
young parents caring for children with developmental disabilities.  Dealing with severe 
cognitive difficulties and behaviours that are problematic and distressing are the main 
challenges of such caring (Floyd and Gallagher, 1997; Hastings et al., 2006; Higgins et 
al., 2005; Maes et al., 2003).  Few previous studies have examined the impact of 
caregiver stress on immunity in relatively young caregivers per se, let alone in parents 
caring for a child with a developmental disability.  Table 1 provides a summary of the 
studies of young caregivers and the immune outcomes.  As can be seen, caregivers were 
daughters, mothers, adult children, and spouses.  Not all studies employed a case-control 
design and, in those that did, there were few differences between caregivers and controls 
in immune function.  Exceptions were the observation that mothers of pre-term infants 
showed a poorer in vitro proliferative response to mitogens than mothers of full-term 
infants (Gennaro et al., 1997) and that mothers of children with cancer had lower 
glucocorticoid sensitivity than parents of healthy children (Miller et al., 2002).  For the 
most part, these studies examined the consequences for immunity of caring for someone 
with a physical rather than a mental health problem.  In only one was the care-recipient a 
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child with an developmental disability; caregivers had a lower T helper: suppressor ratio 
than controls (Pariante et al., 1997).  
 
  [Insert Table 1 about here] 
 
       Although possible physiological mediators of the diminished antibody responses in 
elderly caregivers have received some attention (Kiecolt-Glaser et al., 1996; Li et al., 
2007; Vedhara et al., 1999a), consideration of psychological and circumstantial 
mediators has been sparse (Vitaliano et al., 2003).  Research has identified caregiver 
burden as a potent contributor to psychological distress in various caregiver groups 
(Beach et al., 2000; Cooper et al., 2007; Garand et al., 2005).  For those parents caring 
for children with developmental disabilities, child problem behaviours emerge as an 
additional factor (Gallagher et al., in press,d; Hastings and Brown, 2002).  Further, 
perceived stress and depression have been associated with a reduced antibody response 
in older caregivers (Li et al., 2007), and caregivers almost invariably differ from controls 
in the social support they can draw on; those who are socially isolated appear to suffer 
poorer immunity (Baron et al., 1990; Kiecolt-Glaser et al., 1987).  Consequently, it is 
possible that a poor antibody response to vaccination will be particularly evident in 
parental caregivers who are more distressed, socially isolated, burdened, and report more 
child problem behaviours.   
 
     The present study compared the responses to pneumococcal vaccination of relatively 
young parents caring for a child with a developmental disability and parents caring for a 
typically developing child.  As such, it is the only study that we know of that has examined 
antibody response to vaccination in parents caring for a child with a developmental 
disability.  In addition, these particular caregivers provide an optimal model for testing 
whether the poorer antibody response to vaccination observed in older caregivers of 
dementia patients is specific or generalizes to younger caregivers with similar or even 
greater caregiving demands, i.e., is it the age of the caregiver that mainly matters or the 
characteristics of the care recipient?  Finally, by measuring psychological and caregiving 
characteristics of our participants in greater detail than previous caregiving studies, we also 
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aspired to shed light on the psychosocial determinants of any impairment in antibody 
response in the present caregivers.  It was hypothesized that parents of children with 
developmental disabilities would report substantially more distress and exhibit a poorer 
antibody response.  We also explored whether it was distress, social support, burden, or the 
child’s problem behaviours that was most strongly associated with any impairment in 
vaccination response.   
 
2. Methods 
 
2.1. Participants  
 
      Thirty-two parents caring for children with developmental disabilities and 29 parents 
of normally developing children attended the baseline session.  Developmental 
disabilities is the term used to describe conditions including but not limited to Autism 
spectrum disorders and Downs syndrome (National Institute of Child Health and 
Development, National Institute of Health- http://www.nih.gov/icd/).  These parental 
caregivers were recruited via invitation letters distributed by their respective associations 
and by advertising in syndrome newsletters, and by direct contact with family support 
groups.  Inclusion criteria for these parents were: caring for at least one child with 
Autism, Downs, Cornelia de Lange, or Smith-Magenis syndromes.  Since the emotional 
reaction of parental caregivers is highly influenced by the diagnostic process 
(Graungaard and Skov, 2007), we aimed to avoid this particular event and focus on the 
parents’ stressful experiences of caring per se.   Thus, in keeping with existing research 
(Hastings et al., 2006), children with developmental disabilities had to be aged between 3 
and 19 years and living at home during the school term.  These children attended either 
‘special needs’ schools or had ‘special need provision’ in main stream school.  The 
majority of parents reported caring for a child with Autism (66%); the remainder were 
caring for a child with Downs (22%) or with other syndromes (12%).  Controls, i.e. 
parents of typically developing children who were in the same age range as the disabled 
sample, were recruited via local schools, media campaigns and newspaper 
advertisements.  One caregiver parent reported that he had previously received the 
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pneumococcal vaccine and was thus was excluded from participation.  No other parents 
had received the pneumococcal vaccine previously or had a history of negative reactions 
to blood sampling (e.g., fainting).  None reported suffering from a current acute 
infection, chronic medical condition, or immune disorder (e.g., glandular fever), or 
taking prescribed medication (excluding the contraceptive pill).  None of the female 
participants reported that they were pregnant.  Attempts were made to match the groups 
as closely as possible on age, sex, socioeconomic position, ethnicity, and marital status, 
by recruiting individual parents of normally developing children that matched as near as 
possible individual parents of children with developmental disabilities.  
 
2.2. Study design and procedure 
 
      This was a prospective case-control study involving three testing sessions: baseline, 
1-month and 6-month follow-up.  At baseline, parents completed questionnaires and then 
provided a blood sample to determine baseline antibody status.  After medical screening, 
they were vaccinated with the 23-valent polysaccharide pneumococcal (Pneumovax II; 
Sanofi Pasteur MSD) vaccine via subcutaneous injection in the upper arm.  Following 
vaccination, parents were asked to return one month later (mean lag = 31, SD = 4, days) 
and six months later (mean lag =183, SD = 5, days) to provide a further venous blood 
sample for measurement of antibody titre.  Antibody data were available for 59 
participants at the first follow-up and 56 at the later follow-up. One caregiving parent 
relocated and was therefore unable to attend their next appointments; the remaining three 
parents who were not available for the final follow-up cited issues of family 
commitments as the main reason for non-attendance.  The choice of follow-up times was 
dictated by wishing to capture both the peak IgG response and the subsequent decay. 
 
2.3. Questionnaires 
 
2.3.1. Depression  
      Parental depression was measured using the Hospital Anxiety and Depression Scale 
(HADS) (Zigmond and Snaith, 1983).  The scale contains 14 four-point items, from 0, 
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not present, to 3, considerable, with seven assessing largely the anhedonic rather than 
somatic aspects of depression (e.g., ‘I have lost interest in my appearance’) and seven 
assessing anxiety (e.g., ‘I feel tense or wound up’).  The item scores were added to yield 
sub-scale scores for depression and anxiety from zero to 21.  In the present study, only 
the depression subscale was used.  The HADS has good concurrent validity (Bramley et 
al., 1988; Herrmann, 1997).  For the present sample, Cronbach’s α was .86 for the 
depression subscale. 
 
2.3.2. Perceived stress 
      Psychological stress over the previous month was measured using the 14-item 
Perceived Stress Scale (Cohen et al., 1983).  This scale used extensively in caregiver 
research (Glaser et al., 2000; Vedhara et al., 2002), measures the degree to which 
individuals appraise situations in their lives as stressful over the last month.  Scale 
responses ranged from 0, never, to 4, very often, with higher scores indicating greater 
perceived stress.  This scale shows good test–retest reliability (r = .80) and internal 
reliability (Cronbach’s α = .75).  In the present study, a high internal consistency was 
observed, α = .88. 
 
2.3.3. Social support 
      Social support was assessed using the 12-item Support Functions Scale (Dunst et al., 
1988).   Parents rated each source of support available to them including practical (e.g. 
‘someone to help take care of my child’) and emotional (e.g. ‘someone to talk to about 
things that worry me’) support on a 5-point Likert scale ranging from 1, never, to 5, quite 
often.  This scale has been shown to be reliable (Cronbach’s α = .86) and has been used 
previously in developmental disability research (White and Hastings, 2004).  A high 
internal consistency (α = .89) was also evident for the present sample. 
 
2.3.4. Caregiver Burden 
      As a measure of parental caregiver burden, an adapted version of the 22-item 
Caregiver Burden Index was used (Zarit et al., 1986).  This index was designed to assess 
the stresses experienced by family caregivers of elderly and disabled persons.  Questions 
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were amended replacing ‘your relative’ with ‘your child’.  Examples of items include 
‘Do you feel that because of the time you spend with your child that you don’t have 
enough time for yourself?’, ‘Are you afraid what the future holds for your child?’, and 
‘Overall, how burdened do you feel in caring for your child?’.  Responses ranged from 0, 
never, to 4, nearly always.  The scale has also been used previously in caregiver research 
(Vedhara et al., 2002).  Internal consistency in the current sample was .94. 
 
2.3.5. Child problem behaviour 
      The 25-item Strengths and Difficulties Questionnaire (Goodman, 1997), was used to 
screen for child problem behaviour.  The measure has five subscales, with one assessing 
prosocial behaviour (e.g. ‘kind to younger children’) and four assessing problem 
behaviour; emotional symptoms (e.g. ‘often unhappy, downhearted or tearful’), conduct 
disorder (e.g. ‘often argumentative with adults’), hyperactivity (e.g. easily distracted, 
concentration wanders’), and peer relationships (e.g. rather solitary, tends to play alone’).  
Parents are asked to rate whether a behaviour is 1, true, to 0, somewhat true or 2, 
certainly true, of their child with higher scores indicating more problem behaviour.  
Some items are reversed scored (e.g. generally obedient, usually does what adults 
request).  The scale has been shown to be reliable (Cronbach’s α = .76) and effective at 
identifying behavioural problems in children (Goodman and Scott, 1999).  Further, it has 
been used extensively in research with children with developmental disabilities (Hastings 
et al., 2006).  Internal consistency for the whole scale in this study was .88.  For the 
purpose of our analyses both total and subscale scores were used.  
 
2.4. Control and confounding variables  
 
2.4.1. Health behaviours  
      As in our previous research (Burns et al., 2003a; Phillips et al., 2005; Phillips et al., 
2006) typical health behaviours were assessed at baseline, using a questionnaire adapted 
from the Whitehall II study (Marmot et al., 1991).  Participants were asked, on average 
how much they smoked (0, 1–5, 6–10, 11–20, and 21+ cigarettes per day); how much 
alcohol they drank (0, 1–5, 6-10, 11–20, 21–40, and 40 + units per week).  A simple 
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categorical scoring method was used in all cases.  Participants were also asked how 
much time they spent in activities of light, moderate and vigorous exercise intensity 
which were summed to yield a composite exercise score.  They also indicated how 
regularly they ate certain foods from a standard list, and this information was summed to 
give a measure of fruit and vegetable consumption and fat intake.  
 
2.4.2. Sleep Quality  
      Sleep quality was measured by the 19-item Pittsburgh Sleep Quality Index (Buysse et 
al., 1989).  This index has seven components including subjective sleep quality, sleep 
latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping 
medications, and daytime dysfunction with scores ranging from 0, no problems in area,  
to 3, high problem area.  By summing component scores a total sleep quality score was 
obtained that ranges from 0, good sleep quality, to 21, poor sleep quality. 
 
2.4.3. Time spent caregiving  
      Amount of time spent caregiving was assessed using a modified version of the 
Caregiver Activity Survey (Davis et al., 1997).  Rather than asking parents how much 
time they spend providing care each day to their child, this survey asks parents how 
much time on five specific (e.g. transport, dressing, eating, bathing and supervision) 
caring roles in any one.  Hours for each caring role were summed together to yield a total 
daily score for time spent caregiving.  
 
2.5. Blood sampling and antibody analysis 
 
      Venous blood specimens were collected from an ante-cubital vein into two 7-ml plain 
tubes (BD Vacutainer, Meylan Cedex) to assess antibody titres.  Samples were allowed 
to clot at room temperature for 1 h and centrifuged at 3500 rpm for 5 min.  The separated 
serum was frozen at −20°C until assayed.  Luminex technology was used to assess seven 
pneumococcal (Pn) IgG antibody serotypes (types 1, 3, 6, 9, 14, 19 and 23) contained in 
the pneumococcal vaccine.  Assessment and selection of these specific Pn serotypes were 
based on clinical observations linking these common serotypes to invasive disease in 
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Europe (Denham and Clarke, 2005; Sleeman et al., 2001).  Further details of this assay 
are described elsewhere (Ferraro et al., 2008; Gallagher et al., 2008a; Lal et al., 2005).  
Serum samples were diluted 1:4000 in diluent buffer that additionally contained 5μg/ml 
purified pneumococcal serotype 22F in accordance with the WHO protocol for ELISA 
detection of Pn antibody (http://www.vaccine.uab.edu/#), were run in duplicate, and read 
on a Luminex 100 machine (Luminex Corp, TX, USA).  Acquisition software (BioPlex 
Software Manager (version 4, BioRads, Labs, CA, USA) was used to generate serotype 
antibody concentrations from a 5 parameter logistic curve fit.  Serum Pn IgG levels are 
reported in μg/L.  
 
2.6. Statistical analyses  
 
      Analysis of variance (ANOVA) and chi-square were employed to assess group 
differences in demographics, health behaviours, and psychosocial status.  Prior to 
statistical analyses, the antibody data were checked for assumptions of fit and normality.  
Screening revealed two outliers and skewed antibody data.  One outlier (caregiver) was 
removed for the type 1 strain and one (control) for the type 23 strain and both were 
removed from the average titre.  These two participants registered biologically unfeasible 
values for at least one of the follow-ups.  For one, this took the form of registering a 700-
fold increase in titre relative to a 12-fold mean increase for the participants as a whole 
and for the other, an 80-fold increase relative to a 4-fold increase.  These exclusions are 
reflected in the slight variations in degrees of freedom.  Given the skew of the data, 
antibody titres were subjected to log10 transformation for the main analyses.  Partial eta- 
squared (η2p) is reported as a measure of effect size.  Analysis of covariance (ANCOVA) 
was used to test for group differences in antibody titre at each follow-up separately; 
baseline antibody titre was always entered as a covariate.  We have used the analytic 
strategy of representing antibody response as the follow-up antibody titre adjusted for the 
baseline titre throughout our previous studies (Gallagher et al., 2008a, 2008c; Phillips et 
al., 2005; Phillips et al., 2006).  The approach of analyzing the two follow-ups separately 
is also identical to the one we have used in previous vaccination research (Gallagher et 
al., 2008a, 2008c; Phillips et al., 2005; Phillips et al., 2006).  It was in this case further 
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justified by the results of Glaser et al., (2000), who found caregiver control differences 
only at six months following vaccination, and by, in a small study with some attrition, 
our desire to optimize our degrees of freedom and hence our power to detect effects.  
Where significant group effects emerged, subsequent ANCOVAs were undertaken to 
adjust for potential confounding variables.  The major dependent variables were the 
average IgG titres of the seven strains at the two follow-ups.  However, sensitivity 
analyses using the seven individual Pn polysaccharide serotypes were also undertaken.  
A clinically adequate response to the 23-valent pneumococcal vaccine has been 
determined as a two-fold or greater rise in aggregate antibody titre (Center for Disease 
Control, 1989).  For illustration purposes, this criterion was adopted and the number of 
non-responders in each group compared using chi-square.  Hierarchical linear regression 
analyses were used to determine whether any of the caregiving or psychosocial variables 
predicted log10 antibody level at each follow-up.  In these regression models, antibody 
levels at baseline were entered at step one, parental groups at step 2 and caregiving and 
psychosocial variables entered separately at step three.  Mediation analysis was then 
conducted to determine whether the caregiving or psychosocial variables mediated any 
variation between groups in antibody response.   
 
3. Results  
 
3.1. Demographic, childcare and psychosocial characteristics of parental groups 
 
      The demographic and summary childcare characteristics of the two parental groups 
are presented in Table 2.  It is evident that the groups are reasonably well matched on 
most variables.  However, parents of children with developmental disabilities were 
slightly older on average, their child was older; they were less likely to be currently 
employed outside the home and spent more time caregiving.  They also reported poorer 
sleep quality.  Where appropriate, the analyses adjusted for these variables.  There were 
no differences between groups in health behaviours such as alcohol consumption and 
smoking.   As might be expected, parents caring for a child with a developmental 
disability had much higher levels of depressive symptomatology and perceived stress, 
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reported poorer social support, greater caregiving burden, and more child problem 
behaviour than parents of typically developing children (see Table 2) 
 
[Insert Table 2 about here] 
 
3.2. Antibody response to vaccination  
 
      The mean (SE) actual antibody levels (μg/L) for the average pneumococcal titre, and 
for each of the seven targeted individual strains, at each time point for each of the groups 
is displayed in Table 3.  The average antibody titre rose from baseline to 1-month follow-
up for both groups and, although there was some subsequent decline, antibody levels 
were still higher at the 6-month follow-up than at baseline.  A broadly similar pattern 
was observed for each of the individual strains for each of the groups.  There was no 
significant difference between groups in average pneumococcal titre at baseline, but 
baseline antibody levels were higher in the caregivers for the type 3 and type 19 strains. 
 
[Insert Table 3 about here] 
 
3.3. Caregiving and antibody response  
 
       After adjusting for baseline log10 antibody levels, the aggregate log10 antibody titre 
at both follow-ups differed significantly between parental groups.  Parents caring for 
children with developmental disabilities had a much poorer antibody response than 
parents of typically developing children, at both the 1-month, F(1, 57) = 5.65, p = .02, η2p 
= .095, and the 6-month follow-up, F(1, 50) = 7.14, p = .01, η2p  = .125.  The η2p values 
signify medium to large effects (Cohen, 1988; Pierce et al., 2004).   A repeated measures 
ANCOVA, with both follow-ups included, confirmed these group differences, F(1, 50) = 
6.86, p = .01, η2p  = .121.  As an indicator of a clinically protective antibody response, a 
two-fold increase in antibody titre from baseline to follow-up was used; individuals not 
achieving a two fold response were classified as non-responders.  Parents of children 
with developmental disabilities were more likely to be non-responders than parents of 
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typically developing children at both the 1-month (20% versus 4%) and the 6-month 
(48% versus 4%) follow-up (see Figure 1).  Health behaviours including smoking, diet, 
exercise, and alcohol consumption were unrelated to antibody response.  It is thus 
unsurprising that the differences reported above withstood adjustment for these variables 
in ANCOVA.  Further, because age of parents and care recipient, work outside the home, 
time caregiving and sleep quality differentiated groups, these were also entered as 
covariates.  The main outcomes also remained unchanged following adjustment for these 
variables.   
 
[Insert Figure 1 about here] 
 
3.4. Sensitivity analysis for caregiving and antibody response to individual strains  
 
      Sensitivity analysis was undertaken to establish which pneumococcal serotypes 
differed between parental groups.  At both follow-ups, parents of children with 
developmental disabilities had a poorer response to the type 1 strain, F (1, 55) = 6.97, p 
=.01, η2p = .112, and F (1, 51) = 6.68, p =.02, η2p = .100, respectively, and the type 6 
strain, F (1, 55) = 4.59, p =.04, η2p = .112 and F (1, 51) = 12.57, p >.001, η2p = .198, 
respectively.  At 6-month follow-up, the group difference in response to type 3 strain 
approached significance, F (1, 52) = 3.62, p =.06, η2p = .065, with parental caregivers 
tending to mount a poorer response.   
 
3.5. Contribution of depression, perceived stress, social support, caregiver burden and 
child problem behaviour to group differences in antibody titre 
 
      In hierarchical linear regression analysis in which baseline titre was entered at step 1 
and parental group at step 2, and each psychosocial variable entered individually at step 
3, only child problem behaviour, β = -.29, t = 2.33, p =.02, ΔR2 = .03, abolished the 
between group effect for the 1-month antibody response.  In these analyses, the β for 
parental group changed from -.20 at step 2 to .04 at step 3.  Accordingly, we tested for 
mediation using the Goodman test (Goodman, 1960).  This revealed evidence of 
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mediation, z = 3.09, p <.001.  Thus, it would seem that child problem behaviour was not 
only associated with the 1-month antibody titre independently of parental group in this 
model, but also appeared to account for the caregiver/control group differences in 
antibody response.  The outcome of the mediation analysis is presented in Figure 2.  
Further, analysis of the questionnaire subscales indicated that it was conduct behaviours 
that were primarily responsible; the β for parental group changed from -.20 at step 2 to -
.09 at step 3.  Similar analyses were undertaken with the 6-month antibody titre as the 
dependent variable.  In these analyses no associations emerged between the psychosocial 
variables and antibody titre.  In addition, the associations reported above withstood 
adjustment for demographic variables, other caregiving variables, and health behaviours, 
including sleep quality.  
 
[Insert Figure 2 about here] 
 
3.6. Within case group antibody analyses  
 
      In hierarchical linear regression analyses, again adjusting for baseline titre, no 
significant associations emerged between any of the psychosocial variables and antibody 
response of parents caring for a child with developmental disabilities.  However, 
although not meeting the conventional criterion for statistical significance, there were 
indications of a negative association between child problem behaviour and 1-month 
antibody response, β = -.19, t = 1.57, p = .12, ΔR2 = .04.  Again, it was conduct problems 
that tended to be associated 1-month antibody response, β = -.20, t = 1.61, p = .12, ΔR2 = 
.04.  Moreover, when these parents were divided into those reporting high and low 
conduct problems in their children using a median split, ANCOVA revealed a significant 
effect, F (1, 25) = 4.51, p = .04, η2p = .153; parents caring for a child with developmental 
disabilities who reported that their children showed more conduct problem behaviours 
mounted a poorer antibody response at 1-month (see Figure 3).  No associations emerged 
between any of the psychosocial and circumstantial factors for the 6-month antibody 
titre. 
 
Post-print, not final published version. Cite this article as:  Gallagher, S., Phillips, A.C., 
Drayson, M., & Carroll., D. (2009, invited article). Parental caregivers of children with 
developmental disabilities mount a poor antibody response to pneumococcal vaccination. Brain, 
Behavior & Immunity, 23, 338-346. DOI: 10.1016/j.bbi.2008.05.006. 
http://dx.doi.org/10.1016/j.bbi.2008.05.006 
 
 16
 [Insert Figure 3 about here] 
 
4. Discussion  
 
      Parents caring for children with developmental disabilities exhibited a poorer antibody 
response to a pneumococcal vaccination than parents caring for typically developing 
children at both 1-month and 6-month follow-ups.  Of the variables considered it would 
appear to be child problem behaviour which mediated this effect.  In addition, within the 
parental caregiving group, parents reporting more child conduct problems, a component of 
the child problem behaviour measure, mounted a poorer antibody response at 1-month than 
parents reporting less conduct problems.  
 
       Adopting the criterion of a two-fold antibody response as indicative of clinical 
protection, 20% of parents caregiving for a child with a developmental disability failed to 
mount an adequate response compared to only 4% of controls at 1-month follow-up.  At 6-
months, almost half (48%) did not meet the two-fold criteria compared with 4% of controls.  
Thus, a negative impact of caregiving on vaccination response would not appear to be 
restricted to older individuals caring for spouses with dementia (Glaser et al., 2000; 
Kiecolt-Glaser et al., 1996; Vedhara et al., 1999a), and, accordingly, would not seem to 
require an ageing immune system in order to manifest itself.  Rather, our results suggest 
that it is the characteristics of the caregiving experience per se that is the key determinant 
of its impact on immunity.  Variations in caregiving experience could also explain the 
discrepancy in outcomes between the present study and the earlier finding that younger 
spousal caregivers of multiple sclerosis patients did not differ from controls in antibody 
response (Vedhara et al., 2002).  A cursory comparison of the two studies reveals that the 
present caregivers reported much higher perceived stress (Mean 30.33 +  8.40) and 
caregiver burden (Mean 44.0 + 14.26), than those caring for spouses with multiple sclerosis 
(Mean 25.42 +  8.45) and (Mean 29.00 + 14.80) respectively, t (70) = 2.46, p =.01, and, t 
(70) = 4.31, p <.001.  Although neither perceived stress nor caregiver burden accounted for 
the differences between groups in antibody responses they correlated highly with child 
behaviour problems in the sample as a whole, as well as within the caregiving group (r = 
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.49 to .76).  It is also possible that differences in vaccination, pneumococcal versus 
influenza, might also have contributed to the differences in results.  However, it is worth 
noting that responses to both vaccinations have been found to be compromised in those 
caring for spouses with dementia (Glaser et al., 2000; Kiecolt-Glaser et al., 1996; Vedhara 
et al., 1999a).  
 
      The present study is not only the first to study caregivers of children with developmental 
disabilities in this context, it is also only the second to examine the responses of caregivers to 
pneumococcal vaccination.   In the previous study, older spousal caregivers showed a poorer 
response to pneumococcal vaccination relative to former caregivers and non-caregiving 
controls, but only at the final 6-month follow-up (Glaser et al., 2000).  Although, the 
difference between caregivers and controls in the present study was larger at the later follow-
up, the groups still differed significantly at the earlier 1-month follow-up.  More demanding 
caregiving could again provide an explanation for the earlier effect in the present study.  In 
support of this, perceived stress, measured on the truncated scale, was much higher among the 
present parental caregivers than that reported for the spousal caregivers of patients with 
dementia (Mean 22.23 +  7.27 versus Mean 16.73 +  2.82), t (39) = 3.52, p <.001. Again 
caution is warranted, since perceived stress did not account for the differences between 
groups in vaccination response.   
 
      In analyses of the individual pneumococcal IgG antibody serotypes, parents of children 
with developmental disabilities mounted a poorer response to type 1 and type 6 strains at both 
follow-ups, and to type 3 at 6-months.   It appears that some Pn serotypes are more 
susceptible to psychosocial influence.  Such specificity has also been reported from other 
studies using polyvalent vaccinations (Phillips et al., 2005; Phillips et al., 2006; Pressman et 
al., 2005; Vedhara et al., 1999a).  Indeed, in a recent study of students, social support was 
associated with antibody response to pneumococcal vaccination and it was types 1 and 3 
again which appeared to be particularly sensitive (Gallagher et al., 2008a; 2008c).  One 
explanation for such specificity is that antigens that are less immunogenic are more 
susceptible to exogenous influence (Cohen et al., 2001).  It is worth noting in this regard that 
some of the smallest antibody titres at follow-up were observed for the types 1 and 3 strains.   
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      We also explored whether it was distress, social support, burden or the child’s problem 
behaviour that was most strongly associated with any impairment in vaccination response.  
Despite group differences on all psychosocial and circumstantial measures, no associations 
emerged between depression, perceived stress, social support, or caregiver burden and 
antibody responses at either follow-up.  However, child problem behaviour was a significant 
predictor of 1-month antibody response and a formal test of mediation confirmed it as a 
candidate mediator.  Thus, it appears that child problem behaviour was not only associated 
with antibody titre independently of parental group, but also contributed substantially to the 
caregiver/control group differences in the antibody response.  In addition, subscale analysis 
indicated that conduct behaviours (e.g., often has temper tantrums, often fights with other 
children) were primarily responsible for this effect.  Further, within the caregiving group, 
those parents reporting more problems with conduct behaviour showed a poorer response to 
vaccination compared to those reporting less conduct behaviours.  The negative association 
between care recipients’ problem behaviour and antibody responses is broadly in line with the 
results of research on caregivers of patients with mental health difficulties using other health 
outcomes.  For example, not only have problem behaviours been associated with caregivers’ 
psychological distress (Mausbach et al., 2006; Pinquart and Sorensen, 2003a, b), they have 
also been linked to increased incidence of infectious illness (Dyck et al., 1999) and the onset 
of cardiovascular disease (Mausbach et al., 2007).  The current findings reinforce the 
importance of targeting child problem behaviours in interventions for those caring for a child 
with a developmental disability.  There is preliminary evidence that managing behaviour 
problems in dementia patients can enhance caregivers’ in vitro immunity immediately after 
intervention and 6-months later (Garand et al., 2002).    
 
      The current study has a number of limitations.  First, our sample size might be regarded 
as small.  Nevertheless, it is of a similar order of magnitude to that of other published case-
control studies (Glaser et al., 2000; Vedhara et al., 2002).  Second, it is possible that our 
sample was biased and included more parents from support groups, who were particularly 
stressed.  However, contacted but non-participating parents almost invariably cited 
geographical distance from the University, or an unwillingness to give blood or receive a 
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vaccination as their reasons for not participating.  Third, there were group differences in 
baseline titre, but these were not significant for the average pneumococcal titre or for five 
of the seven strains.  There has been speculation on the effects or prior antigenic exposure 
on subsequent capsular polysaccharide vaccination responsiveness, with some studies 
finding higher antibody concentration and others lower (see Artz, et al., 2003; Davison et 
al., 1994; O’Brien et al., 2007).  Importantly, in the present study, the strains that differed 
significantly between groups in vaccination response (types 1 and 6) were not among those 
showing a significant group difference at baseline.  Thus, our results for vaccination 
response are unlikely to be an artifact of baseline antibody status.  Fourth, there is also the 
possibility of confounding as a result of unmeasured or poorly measured variables.  
However, our main findings survived statistical adjustment for the more common health 
behaviours and any group differences that emerged as a result of imperfect matching.  
Finally, in the absence of appropriate measurement we can only speculate about underlying 
biological mechanisms.  Nevertheless, in caregivers of dementia patients a higher cortisol 
awakening response was found for those reporting high versus low levels of behavioral 
problems in the care recipients (de Vugt et al., 2005).  Further, secretion of this stress 
hormone was inversely associated with antibody response to influenza vaccination in 
caregivers of dementia patients (Vedhara et al., 1999b).  Such variations in cortisol may 
provide one pathway through which problem behaviours exert an influence on antibody 
response to vaccination.  
 
      In conclusion, the negative impact of caregiving on antibody response to vaccination is 
not restricted to older spousal caregivers, but is also evident in younger parents caring for 
children with developmental disabilities.  Relative to parents of typically developing 
children, such caregivers mounted a poorer response than controls to a pneumococcocal 
vaccine at 1-month and showed poorer maintenance at 6-months.   The strongest and most 
consistent predictor of group differences in antibody response, as well as individual 
variations in response within the group of parents of children with developmental 
disabilities, was child problem behaviour.  Analyses of its subscales indicated that it was 
conduct behaviours that underlay these effects.  Thus, the behavioural characteristics of the 
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care recipients may be a key determinant of whether or not immunity is compromised in 
this context.   
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Table 1.  Caregiving and immunity in relatively young (< 60 years) caregiving samples 
 
Author Care recipient + 
carers 
       Age Psychological  
measures  
    Immune measures Results 
 CG        CO
Baron et al., 
(1990) 
Cancer patients 
 + spouses  
48.2           - Depression, social 
support, life events  
Response to mitogens: Con 
A, PHA, NK activity and 
enumerative cell counts  
 
Within CG better social support =  greater proliferation to PHA, and NK 
activity  
Cohen & Pollack 
(2005) 
Mothers with breast 
cancer 
+ daughters 
37.5           - 
 
 
Emotional symptom 
checklist. Life disruption 
and  time helping 
 
Response to mitogens: 
PHA, LPS; IL-2, IL-12, 
cortisol and catecholamines  
Within CG: high distress  (advanced disease) = lower cytokines secretion   
 
Epel et al.,  
(2004) 
Chronically ill 
children  
+ mothers 
 Both groups  
       38 
Range 20-50 
 
Perceived stress and years 
since diagnosis 
(chronicity) 
Telomere length and 
telomerase function and 
oxidative stress 
Group differed only on stress 
Within CG, time caregiving  = shorter telomere length + lower activity and 
higher oxidative stress 
 
Gennaro et al., 
(1997) 
 
Preterm infants 
+ mothers 
27              24 Anxiety and depression  Response to mitogens: Con 
A, PHA and PWM and NK 
activity 
  
No difference in distress  
CG less responsive to mitogens  
Immune response ≠ to distress  
Miller et al., 
(2002) 
Children with 
cancer + parents 
36.5           37 Perceived stress, 
depression, affect and 
social support  
Cortisol , Glucocorticoid 
sensitivity, cytokines  
CG reported higher psychological distress  
No difference in baseline cytokine levels; CG had flatter cortisol slopes 
Reduced glucocorticoid sensitivity to IL-6, but not IL-1β or TNF-α 
CG sensitivity improved with tangible support 
 
Pariante et al., 
(1997) 
Developmentally 
disabled children 
+ mothers 
44              45 Burden, dependence 
behaviors, anxiety, 
depression and personality 
Enumerative cell 
count/ratios  
Humoral response to latent 
viruses  
CG more anxious 
CG less % of T-cells; higher ratio of T suppressor/cytotoxic cells; lower T 
helper/suppressor ratio.  
Age + severity of stress  -ve immunity  
 
Provinciali et al., 
(2004) 
 
Disabled older 
adults + adult 
children and 
grandchildren 
 
54              58 
 
Level of disability, 
depression, anxiety, stress,  
QoL , caregiver burden 
 
ACTH, cortisol, prolactin, 
NK activity and number, β-
endorphins. Incidence and 
severity of influenza  
 
 
No group effect 
CG unable to leave disabled person alone had lower NK count + activity   
 
 
Vedhara et al., 
(2002) 
Multiple Sclerosis 
patients + spouses 
46               33 Perceived stress, anxiety, 
depression and caregiver 
burden. 
Antibody response to 
influenza, IFN-γ and IL-4, 
cortisol and DHEA 
CG reported more stress.   
No differences in antibody or cytokine responses 
CO had higher cortisol   
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CG (Care giver); CO (Control); = associated with; ≠ not associated with; -ve = negatively associated;  
Table 2. Demographics, childcare and psychosocial characteristics of each parental group  
 
 
  
Caregivers (N = 30) 
 
Controls (N = 29) 
 
Test of difference 
    
Sex (Female) 23 (76%) 20 (69%)     χ2 (1) = 0.14, p = .70 
Marital status (Partnered) 26 (87%) 20 (70%)     χ2 (1) = 1.76, p = .19 
Ethnicity (Caucasian) 29 (91%) 26 (90%)     χ2 (1) = 0.00, p = 1.00 
Occupational status (Professional) 14 (47%) 16 (55%)     χ2 (1) = 0.15, p = .70 
Currently employed outside the home   22 (73%) 28 (96%)     χ2 (1) = 6.56, p = .005 
Alcohol (1-20 units per week) 28(100%) 25(93%)     χ2 (1) = 0.557, p = .45 
Smoking (non- smoker) 23 (93%) 25 (79%)     χ2 (1) = 1.08, p = .30 
Body Mass Index (SD) 26.7 (4.33) 24.7 (4.10)     F (1,54) = 2.91, p =.09 
Hour spent caregiving (SD) per day 10.6 (8.19) 3.5 (3.53)     F (1,56) = 17.89, p <.001 
Sleep quality (SD) 10.0 (2.55) 7.1 (2.09)     F (1,57) = 23.08, p <.001 
Mean age (SD) years 42.8 (5.95) 39.9 (4.35)     F (1,57) = 4.44, p = .04 
Mean age of main care recipient (SD) years 11.5 (3.41) 8.8 (4.22)     F (1,57) = 7.18, p = .01 
Mean depression score (SD) 8.4 (3.86) 3.2 (2.31)     F (1,57) = 38.40, p <.001 
Mean perceived stress score (SD)  30.33 (8.40) 22.2 (7.48)     F (1,57) = 15.52, p <.001 
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Mean social support score (SD) 31.7 (9.82) 37.9(10.37)     F (1,57) = 5.62 , p =.02 
Mean caregiver burden score (SD)  44.0 (14.26) 22.9 (10.67)     F (1,57) = 40.94, p <.001 
Mean child behaviour problem score (SD) 23.0 (5.97) 9.9 (4.89)     F (1,57) = 84.64, p <.001 
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Table 3.  Mean (SE) antibody titres (ug/L) for the average and the individual pneumococcal serotypes at baseline, 1-month and 6-month 
 follow-up.  
 
Pneumococcal 
titre 
Baseline 1-Month 6-Month 
 
Caregivers  
 
Controls 
 
Caregivers 
 
Controls 
 
Caregivers 
 
Control 
Average  
 
327 
(82) 
 
201 
(99) 
856 
(109) 
937 
(111) 
576 
(76.9) 
847 
(78.3) 
Type 1  
 
42 
(19) 
 
14 
(2) 
162 
(157) 
534 
(157) 
132 
(99) 
353 
(99) 
Type 3  
 
 22 a 
(8) 
 
4 
(1) 
63 
(24) 
78 
(25) 
42 
(24) 
72 
(25) 
Type 6  
 
1125 
(328) 
 
1052 
(674) 
1823 
(396) 
2355 
(411) 
1021 
(282) 
1539 
(294) 
Type 9  
 
135 
(80) 
 
23 
(11) 
285 
(62) 
390 
(63) 
169 
(52) 
302 
(53) 
Type 14  
 
598 
(274) 
 
189 
(70) 
2004 
(417) 
1899 
(424) 
1732 
(298) 
1669 
(304) 
Type 19  
 
  181 a 
(59) 
 
43 
(17) 
788 
(244) 
542 
(248) 
556 
(144) 
537 
(147) 
Type 23  
 
134 
(59) 
 
34 
(9) 
332 
(83) 
363 
(86) 
199 
(66) 
319 
(69) 
a Significant difference (p < .05) between caregivers and controls at baseline.  The follow-up titres are adjusted for baseline. 
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Figure captions 
 
Figure 1.  Percentage of non-responders (less than two-fold increase) from baseline at 1-month 
follow-up (a) and from baseline to 6-month follow-up (b) for each parental group 
 
Figure 2. Mediation analysis of the association between parental group and 1-month antibody 
titre for child problem behaviour; statistics are standardized regression coefficients adjusted for 
baseline antibody titre. 
 
Figure 3.  Mean (SE) antibody titre at 1-month follow-up, adjusted for baseline antibody titre, 
for parents of children with developmental disabilities with high and low reported conduct 
behaviour problems.   
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